Early and midterm outcomes of a bentall operation using an all-biological valved BioConduit™.

ABSTRACT:

Objectives

To analyze the midterm results of aortic root replacement using the valved, all biological, No React®, BioConduit™.

Methods

From 2017 to 2020, we prospectively followed 91 consecutive patients who underwent a Bentall procedure with a BioConduit™ valved graft in our institution. The primary outcomes were aortic bioprosthetic valve dysfunction and mortality according to Valve Academic Research Consortium 3 (VARC3).

Results

Mean age was 70 ± 10 years and 67 patients (74%) were men. Ascending aortic aneurysm (72%), aortic valve regurgitation (51%) or stenosis (20%) and acute endocarditis (14%) were the main indications for surgery. Seventy-four patients (81.3%) were followed up at 1 year. The perioperative mortality was 8% (n = 8), the early, 1 year, mortality

SUBMITTER: Botea R 

PROVIDER: S-EPMC9761648 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature